Mechanism of the Potent Activated Protein C Resistance of Novel Factor V Mutation with W1920R (FV Nara) Relative to R506Q (FV Leiden)

被引：0
|
作者：
Ogiwara, Kenichi [1 ]
Shinozawa, Keiko [2 ]
Nogami, Keiji [1 ]
Matsumoto, Tomoko [1 ]
Nishiya, Katsumi [1 ]
Tsujii, Nobuyuki [1 ]
Yada, Koji [1 ]
Fukutake, Katsuyuki [3 ]
Shima, Midori [1 ]
机构：
[1] Nara Med Univ, Dept Pediat, Kashihara, Nara 634, Japan
[2] Tokyo Med Univ, Dept Mol Genet & Coagulat Disorders, Tokyo, Japan
[3] Tokyo Med Univ, Dept Lab Med, Tokyo, Japan
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：248 / 249
页数：2
相关论文
共 50 条
  • [1] Population study of the G1691A mutation (R506Q, FV Leiden) in the human factor V gene that is associated with resistance to activated protein C
    Braun, A
    Muller, B
    Rosche, AA
    HUMAN GENETICS, 1996, 97 (02) : 263 - 264
  • [2] Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency
    vanBoven, HH
    Reitsma, PH
    Rosendaal, FR
    Bayston, TA
    Chowdhury, V
    Bauer, KA
    Scharrer, I
    Conard, J
    Lane, DA
    THROMBOSIS AND HAEMOSTASIS, 1996, 75 (03) : 417 - 421
  • [3] Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene
    Castaman, G
    Ruggeri, M
    Tosetto, A
    Rodeghiero, F
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (02) : 357 - 358
  • [4] A novel missense mutation of factor V (Factor V NARA: W1920R) manifested thrombosis and demonstrated a positive result of activated protein C resistance assay
    Shinozawa, K.
    Nogami, K.
    Ogiwara, K.
    Matsumoto, T.
    Amano, K.
    Shima, M.
    Fukutake, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 854 - 854
  • [5] Prevalence of factor V Leiden (FV r506q) in Spanish families with hereditary deficiencies of haemostatic proteins
    Tirado, I
    Llobet, D
    Soria, JM
    Coll, I
    Martinez, E
    Borrell, M
    Mateo, J
    Souto, JC
    Morell, M
    Sala, N
    Fontcuberta, J
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS915 - PS915
  • [6] Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden
    Nogami, Keiji
    Shinozawa, Keiko
    Ogiwara, Kenichi
    Matsumoto, Tomoko
    Amano, Kagehiro
    Fukutake, Katsuyuki
    Shima, Midori
    BLOOD, 2014, 123 (15) : 2420 - 2428
  • [7] Testing for resistance to activated protein C factor V R506Q - Reply
    Longtine, JA
    Dorfman, DM
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1998, 122 (12) : 1046 - 1046
  • [8] Activated protein C resistance and the FV:R506Q mutation in a random population sample -: Associations with cardiovascular risk factors and coagulation variables
    Lowe, GDO
    Rumley, A
    Woodward, M
    Reid, E
    Rumley, J
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (06) : 918 - 924
  • [9] Molecular bases of pseudo-homozygous APC resistance: The compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma
    Castoldi, E
    Kalafatis, M
    Lunghi, B
    Simioni, P
    Ioannou, PA
    Petio, M
    Girolami, A
    Mann, KG
    Bernardi, F
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (03) : 403 - 406
  • [10] Factor V Leiden mutation (R506Q) and the risk of advanced retinopathy of prematurity
    Kleinberg, S
    Garrant, S
    Tillen, T
    Trese, MT
    Shastry, BS
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (04) : 469 - 472
12345